Skip to content
Yog Pharma

Topiramate is an antiepileptic indicated for epilepsy and preventive treatment of migraine. We supply it to US manufacturers of tablets, sprinkle capsules and extended-release capsules.

CAS97240-79-4339.4 g/molC12H21NO8S
2D structure of Topiramate.

Data from PubChem (CID 5284627) and FDA’s substance registry

CAS number

97240-79-4

Molecular formula

C12H21NO8S

Molecular weight

339.4g/mol

FDA UNII

IUPAC name

[(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-6-yl]methyl sulfamate

InChIKey

KJADKKWYZYXHBB-XBWDGYHZSA-N

Appearance
White crystalline powder with a bitter taste.
Solubility
Most soluble in alkaline solutions at pH 9 to 10. Freely soluble in acetone, chloroform, dimethyl sulfoxide and ethanol.

Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.

Worth settling with your inquiry

Degrades with heat and moisture, releasing sulfate and sulfamate. Compare the limits for both, and the storage conditions, between sources.

On the US market

Reference product
TopamaxNDA 020505
Approved ANDAs
33 with a marketed product
Approved forms and strengths
  • Extended-release capsule 25 mg, 50 mg, 100 mg, 150 mg, 200 mg
  • Tablet 25 mg, 50 mg, 100 mg, 200 mg
  • Capsule 15 mg, 25 mg, 50 mg
  • Oral solution 25 mg/mL

Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. The brand name belongs to its owner and identifies the reference product only.

Grade

USP or Ph. Eur. where a monograph exists, or your own specification.

Quantities

From development quantities for formulation work to commercial supply.

Packaging

To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.

Regulatory filings

US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.

Documents available with a quote

  • Specification and certificate of analysis
  • Safety data sheet
  • Method of analysis
  • DMF letter of authorization, where a US DMF is filed
  • GMP certificate and inspection history of the site
  • Residual solvents and elemental impurities statements
  • Nitrosamine risk assessment
  • TSE/BSE statement

Need something else for your QA file? Email info@yogpharma.com